跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,233 条关于
“Ytterbium-176”
全部
2,233
临床试验
1,212
药物
720
机构
8
资讯
293
2个月前
Bruce Power Wins Regulatory Approval to Process Cancer-Fighting Lutetium-177 On-Site
去年
ASP Isotopes and Isotopia Forge Strategic Partnership to Accelerate Terbium-161 Cancer Therapy Production
3个月前
SHINE Technologies Secures European Marketing Authorization for Lutetium-177 Radioisotope Ilumira
去年
NeOnc Technologies Strengthens Competitive Edge with 176-Patent Global Portfolio
去年
Psychedelic Drug Developers Atai, Cybin, and GH Research Discuss Trial Design and FDA Expectations
去年
Tirzepatide Shows 94% Risk Reduction in Type 2 Diabetes Progression Over Three Years
去年
Tirzepatide Demonstrates Strong Diabetes Prevention in Obese, Prediabetic Patients
去年
Mounjaro Shows Promise in Preventing Type 2 Diabetes Progression in Phase 3 Trial
去年
Tirzepatide Shows Sustained Weight Loss and Reduces Type 2 Diabetes Risk in Obese, Pre-diabetic Individuals
去年
Tirzepatide Shows Sustained Benefits in Pre-Diabetes and Obesity Over Three Years
第 1 页,共 30 页
上一页
下一页